Related Experiment Video
Updated: May 5, 2026

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
The clinical outcome after coronary bypass surgery: a 30-year follow-up study
Ron T van Domburg1, Arie Pieter Kappetein, Ad J J C Bogers
1Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands. r.vandomburg@erasmusmc.nl
Insights
This 30-year study shows coronary artery bypass graft (CABG) surgery offers a median life expectancy of 17.6 years. However, most patients require repeat interventions, indicating CABG is a palliative treatment for progressive coronary artery disease.
Area of Science:
- Cardiovascular Surgery
- Clinical Outcomes Research
- Long-term Patient Follow-up
Background:
- Coronary artery bypass graft (CABG) surgery is a common intervention for coronary artery disease.
- Understanding the long-term clinical outcomes and life expectancy (LE) after CABG is crucial for patient management.
- Previous studies have provided insights, but extended follow-up data up to 30 years is less common.
Purpose of the Study:
- To investigate the long-term clinical outcomes up to 30 years following coronary artery bypass graft (CABG) surgery.
- To assess the life expectancy (LE) of patients after CABG, analyzing subgroups based on disease severity and cardiac function.
- To evaluate the need for repeat revascularization procedures over three decades post-CABG.
Main Methods:
- Analysis of 30-year outcomes for 1041 patients undergoing venous CABG between 1971 and 1980.
- Comprehensive follow-up every 5-7 years, including hospital records, general practitioners, and civil registries.
- Kaplan-Meier curves used to determine cumulative survival, freedom from re-intervention, and overall life expectancy.
Main Results:
- 30-year survival rates were 77% at 10 years, 40% at 20 years, and 15% at 30 years.
- Overall median life expectancy after first CABG was 17.6 years, varying by extent of vessel disease and left ventricular ejection fraction.
- A high rate of repeat interventions was observed, with 36% of patients undergoing 623 coronary re-interventions by 30 years.
Conclusions:
- The 30-year follow-up provides a near-complete life cycle assessment after CABG.
- Venous CABG is a useful palliative treatment for progressive coronary artery disease, but not a definitive cure.
- Factors such as age, extent of vessel disease, and left ventricular ejection fraction significantly impact long-term mortality and life expectancy.
Aims:
To investigate the long-term clinical outcome (up to 30 years) after coronary artery bypass graft (CABG) surgery and to assess the life expectancy (LE) among subgroups of patients.
Methods And Results:
We analysed the 30-year outcome of the first 1041 consecutive patients in our institution (age at operation 53 years, 88% male) who underwent venous CABG between 1971 and 1980. During follow-up, every 5-7 years follow-up status was obtained by reviewing the hospital records and from general practitioners and civil registries. Data were collected on death and repeat coronary revascularization procedures. Follow-up was complete in 98%. Median follow-up was 29 years (26-36 years). The cumulative 10-, 20-, and 30-year survival rates were 77%, 40%, and 15%, respectively. Overall, 623 coronary re-interventions were performed in 373 patients (36%). The cumulative 10-, 20-, and 30-year freedom from death and coronary re-intervention rates were 60%, 20%, and 6%, respectively. Age [hazard ratio (HR) 1.04/year], extent of vessel disease (VD) (two-VD HR 1.4; three-VD HR 1.9), left main disease (HR 1.6) and impaired left ventricular ejection fraction (LVEF) (HR 1.8) were independent predictors of mortality. We were able to assess the exact LE by calculating the area under the Kaplan-Meier curves. Overall LE after first CABG was 17.6 years. LE in patients with one-, two-, and three-VD was 21.4, 18.8, and 15.4 years, respectively (P < 0.0001). Patients with impaired LVEF had a significant shorter LE than patients with normal LVEF (13.9% vs. 19.3%; P < 0.0001).
Conclusion:
This 30-year follow-up study comprises the almost complete life cycle after CABG surgery. Overall median LE was 17.6 years. As the majority of the patients (94%) needed a repeat intervention, we conclude that the classic venous bypass technique is a useful but palliative treatment of a progressive disease.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease V: Postoperative Nursing Management

